FXC:NYE-Invesco CurrencyShares® Canadian Dollar Trust (USD)

ETF | Single Currency |

Last Closing

USD 72.017

Change

-0.08 (-0.11)%

Market Cap

N/A

Volume

5.65K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Single Currency

Symbol Name Price(Change) Market Cap
FXE Invesco CurrencyShares® Euro ..

-0.44 (-0.43%)

USD 0.19B
FXA Invesco CurrencyShares® Austr..

-0.44 (-0.65%)

N/A
FXB Invesco CurrencyShares® Briti..

-0.03 (-0.02%)

N/A
FXF Invesco CurrencyShares® Swiss..

-0.70 (-0.67%)

N/A
FXY Invesco CurrencyShares® Japan..

-0.80 (-1.27%)

N/A

ETFs Containing FXC

UDN Invesco DB US Dollar Inde.. 0.00 % 0.76 %

-0.11 (0%)

USD 0.07B
USDU WisdomTree Bloomberg U.S... 0.00 % 0.50 %

+0.13 (+0%)

USD 0.21B
UUP Invesco DB US Dollar Inde.. 0.00 % 0.76 %

+0.16 (+0%)

USD 0.32B
GLDW -9.10 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Single Currency) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.52% 33% F 20% F
Dividend Return 1.82% 60% D- 36% F
Total Return -0.70% 50% F 20% F
Trailing 12 Months  
Capital Gain 0.67% 33% F 18% F
Dividend Return 2.28% 60% D- 32% F
Total Return 2.95% 33% F 18% F
Trailing 5 Years  
Capital Gain -2.77% 50% F 40% F
Dividend Return 3.91% 100% F 11% F
Total Return 1.14% 50% F 27% F
Average Annual (5 Year Horizon)  
Capital Gain -0.35% N/A N/A 34% F
Dividend Return 0.29% N/A N/A 26% F
Total Return 0.64% N/A N/A 16% F
Risk Return Profile  
Volatility (Standard Deviation) 5.16% N/A N/A 91% A-
Risk Adjusted Return 5.63% N/A N/A 28% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike